Sangamo Therapeutics Inc (SGMO) – key numbers that make it a Strong Buy For Now

Sangamo Therapeutics Inc (NASDAQ: SGMO) is 354.63% higher on its value in year-to-date trading and has touched a low of $0.30 and a high of $3.18 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SGMO stock was last observed hovering at around $2.31 in the last trading session, with the day’s gains setting it 0.16%.

Currently trading at $2.47, the stock is 13.84% and 27.17% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 13.65 million and changing 6.93% at the moment leaves the stock 151.88% off its SMA200. SGMO registered 581.57% gain for a year compared to 6-month gain of 425.76%. The firm has a 50-day simple moving average (SMA 50) of $1.9424 and a 200-day simple moving average (SMA200) of $0.98075.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a 26.67% loss in the last 1 month and extending the period to 3 months gives it a 169.95%, and is 20.49% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 21.79% over the week and 13.04% over the month.

Sangamo Therapeutics Inc (SGMO) has around 405 employees, a market worth around $551.06M and $52.29M in sales. Profit margin for the company is -260.33%. Distance from 52-week low is 712.50% and -22.30% from its 52-week high. The company has generated returns on investments over the last 12 months (-203.60%).

with sales reaching $8.84M over the same period.The EPS is expected to grow by 68.33% this year, but quarterly earnings will post -66.44% year-over-year. Quarterly sales are estimated to grow 333.05% in year-over-year returns.

Sangamo Therapeutics Inc (SGMO) Top Institutional Holders

128.0 institutions hold shares in Sangamo Therapeutics Inc (SGMO), with institutional investors hold 27.68% of the company’s shares. The shares outstanding are 208.62M, and float is at 199.09M with Short Float at 7.51%. Institutions hold 27.02% of the Float.

The top institutional shareholder in the company is WASATCH ADVISORS LP with over 20.09 million shares valued at $7.2 million. The investor’s holdings represent 11.1403% of the SGMO Shares outstanding. As of 2024-06-30, the second largest holder is ARMISTICE CAPITAL, LLC with 14.06 million shares valued at $5.04 million to account for 7.7963 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 11.9 million shares representing 6.5977% and valued at over $4.26 million, while BLACKROCK INC. holds 2.6078 of the shares totaling 4.7 million with a market value of $1.69 million.